Puretech Health Plc (PRTC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PRTC Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Puretech Health Plc's ability to sustain operations and capital deployment.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
0 0 0 (Dec 31 2024)
Operating Activities
Income-110.08
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss0.11
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets-0.47
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-29.39
Adjustments For Depreciation And Amortisation Expense-
Adjustment Of Impairment Of Investment In Associate-
Adjustments For Sharebased Payments-
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates-
Adjustments For Gain On Loss Of Significant Influence-
Adjustment For Conversion Of Debt To Equity-
Adjustments For Share Of Net Incomeloss Of Associate-
Adjustments For Income Tax Expense-
Adjustments For Finance Costs-
Adjustments For Decrease Increase In Trade And Other Receivables-
Adjustments For Decrease Increase In Other Current Assets-
Adjustments For Increase Decrease In Deferred Revenue-
Adjustments For Increase Decrease In Trade Account Payable-
Adjustments For Increase Decrease In Other Operating Payables-
Income Taxes Paid Refund Classified As Operating Activities-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities0.00
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities52.59
Discontinued operations0.00
Net Cash flow from Operating Activities-85.13
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.27
Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities145.31
Short-term Investments Acq.0.00
Purchase Of Investments Other Than Investments Accounted For Using Equity Method0.00
Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities-
Other Cash Receipts From Sales Of Equity Or Debt Instruments Of Other Entities Classified As Investing Activities-
Receipt Of Payment Of Sublease-
Purchases Of Convertible Note-
Other Inflows Outflows Of Cash Classified As Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Purchase Of Financial Instruments Classified As Investing Activities-84.05
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Purchase Of InterestsIn Associates-0.89
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.15
Discontinued operations0.00
Net Cash Flow from Investing Activities63.29
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-6.33
Proceeds From Issuance Of Convertible Notes-
Distribution To Tal Shareholders-
Proceeds From Issue Of Preference Shares-
Issuance Of Warrants-
Payments To Acquire Or Redeem Entitys Shares-
Distribution To Shareholders On Dissolution Of Subsidiary-
Subsidiary Dividend Payments-
Increase Decrease In Cash And Cash Equivalents-
Vesting Of Restricted Stock Units-
Proceeds From Issue Of Shares To N C I-
Payment To Purchase Treasury Stock-
Payments From Changes In Ownership Interests In Subsidiaries-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-6.33
Effect of exchange rate on cash flow-28.17
Discontinued operations0.00
Free Cash Flow-84.87
Total Cash Flow280.64
4 historic quarters locked

Sign in to unlock the full Puretech Health Plc cash flow history.

About Puretech Health Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: April 29, 2026
  • Source: ptv-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-028200

Figures are derived from filed reports and may be restated. Historical data is subject to revision.